CareDx, Inc., a molecular diagnostics company focused on the discovery, development, and commercialization of clinically differentiated, high-value diagnostic solutions for transplant patients has agreed to acquire OTTR Complete Transplant Management ("OTTR"), a provider of organ transplant patient tracking software. Financial Details CareDx will pay approximately $16M to acquire OTTR and intends to fund the transaction with ... Read More